Advertise on podcast: Beyond the Clinic: Innovation in Healthcare

In this episode, David Ogman shares the deeply personal journey that reshaped his life; navigating his son’s diagnosis with an ultra-rare genetic disease (TECPR2) and confronting the realities families face when science has few answers. We explore how that experience led David to co-found the Jordan Avi Ogman Foundation, his efforts to drive rare disease research forward, and what his family’s story reveals about the gaps, and opportunities, in how we approach rare diseases today. To learn more or support the work of the Jordan Avi Ogman Foundation, visit: SavingJordan.org

Imagine a world where people with diabetes are having their doors taken off their hinges because they slipped into a coma after missing a dose of insulin, or constantly having to do finger-prick glucose tests at traffic lights mid-commute to the office. With today's glucose monitoring technology it's almost hard to believe, but this is the world that Melissa Holloway experienced as a person with diabetes throughout her time in university and her early career. Now, she's committed to helping people like her to better understand their diabetes and how to get the most out of their continuous glucose monitors (CGMs). In this episode, I sit down with Melissa to learn about her diabetes journey, how that led to founding SmartStart Health, how to avoid £200+ K mistakes when building a tech startup... and much more! Follow Melissa on LinkedIn: https://www.linkedin.com/in/mpfholloway/ Check out SmartStart Health: https://smartstart.health/ Visit Beyond the Clinic on LinkedIn for more content: https://www.linkedin.com/company/beyondtheclinicpodcast/?viewAsMember=true Oscar's LinkedIn: https://www.linkedin.com/in/oscar--vallejo/

In this episode, we sit down with Felix Lorenzen to talk about his latest venture, Autonome—a platform designed to put your health on autopilot. Autonome takes a proactive approach, managing your health behind the scenes so you can stay ahead, not just react. The future of healthcare is clearly preventive, personalised, and always in your pocket - and Felix is building exactly that. Last year, Felix made the move from Europe to San Francisco, drawn by the culture and momentum he needed to bring Autonome to life. Since then, he’s launched the product in beta and is working closely with early users to refine the experience ahead of its full release.

We’re joined by Sam Windsor, CEO and Co-Founder of Ignota Labs - a company tackling one of the biggest hidden inefficiencies in drug development: the lack of insight into why drugs fail. Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients. The company works with R&D teams to revisit failed assets using machine learning and biological context to suggest new hypotheses for why those drugs failed and how they could be rescued or repositioned, reviving the assets and most importantly getting them into the hands of patients. Earlier this year, Ignota Labs raised a $6.9 million seed round, and in this episode Sam shares what they’re building, how they collaborate with partners, and why now is the time for a company like this to exist. Follow Sam on LinkedIn to keep up to date with Ignota Labs’ journey: ⁠www.linkedin.com/in/sam-windsor-002993b2/⁠ For extra content, follow us on LinkedIn: Beyond the Clinic: ⁠www.linkedin.com/company/beyondtheclinicpodcast/⁠ Oscar: ⁠www.linkedin.com/in/oscar--vallejo/⁠ Liz: ⁠www.linkedin.com/in/elizabethannedoyle/⁠

70% of chronic conditions are preventable through lifestyle. Want to prevent these? Well, you need data. Wearable data alone won’t tell you the full picture. It’s only when you incorporate this with clinical results from labs or scans that your data paints a real picture. We sit down with Boris Lipchin, Head of Product at Junction Health who are on a mission to do just that. Activate our otherwise siloed health data and enable an industry to do the same. Listen how Junction aims to power the future of personalised care after recently raising $18m Series A round. Check out Boris on LinkedIn: https://www.linkedin.com/in/blipchin/

David is developing a treatment for CMT1A, a rare disease affecting 1.6 million people worldwide, including his 4-year-old son, Ari. In this episode, we dive deep into Ari's condition, David's motivation for starting Shark Tooth Biotech and his plan for finding a cure for CMT1A. It's not one to miss... Follow David on LinkedIn: https://www.linkedin.com/in/appledavid/

In this week's episode we cover all things Africa. Africa has only 3% of the global health workforce but bears 24% of the global disease burden. What's more? Over 60% of Africa’s population is under 25 years old. (Compared to 30% of UK population). There's high prevalence of: Malaria, HIV/AIDS, and tuberculosis as well as rising rates of diabetes, cardiovascular diseases, and cancer due to urbanisation and lifestyle changes. So how does one make meaningful differences in healthcare here? Oscar and Liz speak with⁠ ⁠Sewu-Steve Tawia to get his insight on just that. He shines light on investing in the continent and how obstacles and opportunities in Africa differ to US & Europe. Follow Sewu on LinkedIn: https://www.linkedin.com/in/stevetawia/ …and check out his own podcast, Tales of an African CEO: https://www.youtube.com/@toac_show

In this episode, we dive into the latest from the 2025 Consumer Electronics Show (CES) and JPM's Healthcare Conference, two of the biggest events in the health and life sciences ecosystem. We share our insights from the events, covering the groundbreaking innovations and investment trends that are shaping the future of healthcare. From CES, we explore the growing role of consumer tech in health, with a focus on AI-powered devices and wearable technologies that are poised to transform patient care. From JPM, we take a deep dive into the future of pharma and biotech investment, including the key M&A and therapeutic trends. We discuss the innovations that dominated the conversations, and where we think the industry is headed in 2025. This episode is packed with insights for anyone looking to stay ahead of the curve in the fast-moving world of health and its investments. If you enjoyed this episode, make sure to follow Beyond the Clinic Podcast on LinkedIn for more health investment and startup content: ⁠linkedin.com/company/beyondtheclinicpodcast⁠

Today’s episode is a very exciting one for 2 reasons: Firstly, because we’re joined by Jon Chee, the Founder and CEO of Excedr - a company that has helped countless life sciences companies live to see another day by providing them with the equipment they need at the times they need it most... and secondly, because this isour very first video episode - which you can watch on Spotify! Jon is entering his 15th year as Founder and CEO, But beyond the business, he’s also the host of The Biotech Startups Podcast and has deep insights into what it takes to grow a company in this space. In this episode, we talk about: 1) Venture Capital’s love of de-risked bets, and what’s going on behind the scenes of today’s biotech investment landscape. 2) The challenges of hiring executives as a startup founder and how getting it wrong can be a costly mistake. 3) How Excedr navigated a critical moment when a major client’s equipment failed, all at once —and what that taught Jon about how to survive in a crisis. 4) The concept of ‘Founder Mode’ and why he thinks a lot of founders can make good CEOs. ...and, on a lighter note, why he might have ended up in the food and wine industry if he hadn't been building Excedr. We really enjoyed speaking to Jon - he’s very open about the good and the bad sides of what it means to be a Founder and we learned a lot from our conversation. Follow Jon on LinkedIn:⁠ linkedin.com/in/jonchee/⁠ For extra weekly content check out Beyond the Clinic on LinkedIn:⁠ linkedin.com/company/beyondtheclinicpodcast/

Kicking off season III, we're joined by Dr. Robert Sargsyan, CEO and Co-Founder of Docus.ai, a company with the mission of combining AI and patient data to support patient care. From starting his first business at 17 to building a revolutionary platform that bridges the gap between patients and clinicians using AI, Robert’s journey is nothing short of inspiring. In this episode, Robert shares the story behind Docus.ai, a groundbreaking solution designed to transform patient care. You’ll hear how his personal experience with a friend’s life-threatening illness sparked the idea for a platform that uses AI-powered assistants to tackle inefficiencies in healthcare; streamlining patient-doctor interactions, preventing misdiagnoses, and empowering patients to take control of their health data. We also explore the challenges of integrating AI in healthcare, the importance of data security and compliance, and the future of AI as the “first touchpoint” in our healthcare journeys. If you’re curious about improving healthcare systems or simply want to understand more about how AI is reshaping the future of medicine, this episode is for you. Drop us a follow if you enjoy and check out Beyond the Clinic Podcast on LinkedIn for extra weekly content: ⁠⁠linkedin.com/company/beyondtheclinicpodcast⁠

Biotech fundraising is consolidating, with fewer startups but bigger rounds. Meanwhile, AI is reshaping drug discovery, and wearables like the Oura ring are making waves in health tech. In this episode, we unpack the trends driving the industry and what they mean for the future of innovation. Curious about where the money - and the technology - is headed? Listen now. Drop us a follow if you enjoy and check out Beyond the Clinic Podcast on LinkedIn for extra weekly content: ⁠linkedin.com/company/beyondtheclinicpodcast

With 18 years of industry experience, Eil is the perfect person to guide us through the world of Big Pharma In this episode, Eil walks us through pharma's decision making process for new investments, the drug development process, the biggest challenges facing the industry today and what he wish he'd known when he joined the industry 18 years ago On top of all that, we dig into case studies that bring these concepts to life: Biogen's Aduhelm, Pfizer and BioNTech's blockbuster COVID-19 vaccine, Novartis' $2M gene therapy Zolgensma, Novo Nordisk's GLP-1 presence... and more! Drop us a follow if you enjoy and check out Beyond the Clinic Podcast on LinkedIn for extra weekly content: linkedin.com/company/beyondtheclinicpodcast

Think about it, when we're in the doctor’s we’re asked about family history, symptoms and alcohol consumption...but never about sleep, diet, stress, exercise or our weight lifting regime - yet, the top 5 conditions affecting men and women have been proven to be reduced or prevented through improving those lifestyle factors That's why we're doublin' down on prevention today and telling you all about the conditions men and women should be aware of and why it's so important to act now Check out Beyond the Clinic on LinkedIn for more content: https://www.linkedin.com/company/beyondtheclinicpodcast/?viewAsMember=true

We're joined by Sarah Ranchev-Hale, Head of Imperial College London's Enterprise Lab to talk about her experience and advice for Founders! Expect to learn: How Sarah supports groundbreaking health and biotech startups like BenevolentAI and DNA Nudge at Imperial What does a unicorn like BenevolentAI look like in the early days and how can you spot a future unicorn? Sarah shares the success stories from previous cohorts like Charco Neurotech’s Founder, Lucy Jung With the rapid advancements in AI, genomics, and digital health, what emerging trends Sarah thinks health corporates and VCs should be paying more attention to for the next wave of innovation ...and more! Check out Sarah on LinkedIn: https://www.linkedin.com/in/sarah-ranchev-hale-75830b27/

We're joined by Dr. DJ Hamblin-Brown, an NHS Doctor turned Founder and CEO of Careful Systems and the architect of the Careful platform (www.careful.online), an inter-operable digital health application for clinicians! The application improves patient safety and patient flow by allowing clinicians to share critical information and tasks during handover and referrals. DJ goes into detail on his experience founding and scaling Careful Systems and the challenges selling into care organisations like the NHS. Check out DJ on LinkedIn: https://www.linkedin.com/in/doctordjbrown/